Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hazzan

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2008
Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effectsDaniel Abramowicz, Karine Hadaya, Marc Hazzan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 15, 2015
Does pre-emptive transplantation versus post start of dialysis transplantation with a kidney from a living donor improve outcomes after transplantation? A systematic literature review and position statement by the Descartes Working Group and ERBPDaniel Abramowicz, Marc Hazzan, Umberto Maggiore, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2004
Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetilMarc Hazzan, François Provot, François Glowacki, et al.
Diabetes & Metabolism|November 15, 2016
Post-transplantation diabetes: Treatment à la carte?Kanza Benomar, Stéphanie Espiard, Claire Vahe, et al.
Langenbeck'S Archives of Surgery|August 16, 2006
Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantationFrederic Triponez, David Dosseh, Marc Hazzan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 2025
Renal Cell Carcinoma in Native Kidney After Kidney Transplantation: A Multicenter Case Control Study With a Focus on Screening StrategyPierre Pommerolle, Maryam Assem, Marine Uhl, et al.
Clinical Pharmacokinetics|May 3, 2011
Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipientsFrançois Glowacki, Arnaud Lionet, Jean-Philippe Hammelin, et al.
Kidney International Reports|May 14, 2019
Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 YearsMathilde Lemoine, Dimitri Titeca Beauport, Thierry Lobbedez, et al.
Nephrologie & Therapeutique|January 4, 2018
[Vancomycin poisoning successfully treated with intermittent hemodialysis: A case report]Jérémy Zaworski, Marie Frimat, Marion Duval, et al.
Scientific Reports|August 31, 2019
Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipientsAghilès Hamroun, Rémi Lenain, Linh Bui Nguyen, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2008
Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effectsDaniel Abramowicz, Karine Hadaya, Marc Hazzan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 15, 2015
Does pre-emptive transplantation versus post start of dialysis transplantation with a kidney from a living donor improve outcomes after transplantation? A systematic literature review and position statement by the Descartes Working Group and ERBPDaniel Abramowicz, Marc Hazzan, Umberto Maggiore, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2004
Improvement in long-term graft survival in cadaveric renal transplant recipients treated with mycophenolate mofetilMarc Hazzan, François Provot, François Glowacki, et al.
Diabetes & Metabolism|November 15, 2016
Post-transplantation diabetes: Treatment à la carte?Kanza Benomar, Stéphanie Espiard, Claire Vahe, et al.
Langenbeck'S Archives of Surgery|August 16, 2006
Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantationFrederic Triponez, David Dosseh, Marc Hazzan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 1, 2025
Renal Cell Carcinoma in Native Kidney After Kidney Transplantation: A Multicenter Case Control Study With a Focus on Screening StrategyPierre Pommerolle, Maryam Assem, Marine Uhl, et al.
Clinical Pharmacokinetics|May 3, 2011
Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipientsFrançois Glowacki, Arnaud Lionet, Jean-Philippe Hammelin, et al.
Kidney International Reports|May 14, 2019
Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 YearsMathilde Lemoine, Dimitri Titeca Beauport, Thierry Lobbedez, et al.
Nephrologie & Therapeutique|January 4, 2018
[Vancomycin poisoning successfully treated with intermittent hemodialysis: A case report]Jérémy Zaworski, Marie Frimat, Marion Duval, et al.
Scientific Reports|August 31, 2019
Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipientsAghilès Hamroun, Rémi Lenain, Linh Bui Nguyen, et al.
Pageof 12